Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory Autoimmune Diseases”

126 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 126 results

Early research (Phase 1)UnknownNCT05474885
What this trial is testing

BCMA-CD19 cCAR T Cell Treatment of Relapsed/Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Relapsed/Refractory, Systemic Lupus Erythematosus (SLE)
iCell Gene Therapeutics 15
Very early researchLooking for participantsNCT07144462
What this trial is testing

Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patients With Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Autoimmune
Neukio Biotherapeutics (Shanghai) Co., Ltd. 8
Early research (Phase 1)Not Yet RecruitingNCT07287930
What this trial is testing

YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 13
Early research (Phase 1)Looking for participantsNCT07224373
What this trial is testing

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
AstraZeneca 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07453368
What this trial is testing

Orelabrutinib in the Treatment of Relapsed/Refractory AIHA

Who this might be right for
Autoimmune Hemolytic Anemia (AIHA)
Peking Union Medical College Hospital 50
Very early researchNot Yet RecruitingNCT06933563
What this trial is testing

UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Zhejiang University 18
Very early researchLooking for participantsNCT07205315
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia (B-ALL)Chronic Lymphocytic Leukemia (CLL)B-cell Non-Hodgkin's Lymphoma (B-NHL)+1 more
Grit Biotechnology 28
Not applicableNot Yet RecruitingNCT06871644
What this trial is testing

Clinical Study of CD7 CAR-T Cells for Relapsed/refractory Autoimmune Diseases

Who this might be right for
Systemic Sclerosis - 2013 ACR/EULAR Classification Criteria
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 18
Not applicableNot Yet RecruitingNCT07149818
What this trial is testing

A Single-arm Phase 2 Prospective Clinical Study of Linprixel in the Treatment of Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
Peking Union Medical College Hospital 22
Very early researchNot Yet RecruitingNCT07535138
What this trial is testing

Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)IgA Nephropathy (IgAN)
Air Force Military Medical University, China 15
Testing effectiveness (Phase 2)Looking for participantsNCT05599880
What this trial is testing

The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia

Who this might be right for
Relapsed/Refractory Immune Thrombocytopenia
Seoul National University Hospital 29
Very early researchNot Yet RecruitingNCT07392528
What this trial is testing

Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMultiple SclerosisMyasthenia Gravis
Tianjin Huanhu Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT07388277
What this trial is testing

CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis

Who this might be right for
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Marcela V. Maus, M.D.,Ph.D. 12
Early research (Phase 1)Looking for participantsNCT07236801
What this trial is testing

Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic SclerosisSjogren's Syndrome (SS)+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Very early researchLooking for participantsNCT07246096
What this trial is testing

Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Autoimmune DiseasesSystemic Lupus ErythematosusSystemic Sclerosis+3 more
Changhai Hospital 60
Not applicableLooking for participantsNCT06973356
What this trial is testing

Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Anhui Provincial Hospital 18
Early research (Phase 1)Study completedNCT07075484
What this trial is testing

YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
China Immunotech (Beijing) Biotechnology Co., Ltd. 7
Early research (Phase 1)Not Yet RecruitingNCT07453836
What this trial is testing

Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
China Immunotech (Beijing) Biotechnology Co., Ltd. 13
Not applicableStudy completedNCT00307593
What this trial is testing

RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides

Who this might be right for
Wegener's GranulomatosisChurg-Strauss SyndromeMicroscopic Polyangiitis
Assistance Publique - Hôpitaux de Paris 20
Not applicableLooking for participantsNCT06797024
What this trial is testing

JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders

Who this might be right for
Autoimmune Diseases of the Nervous System
Tongji Hospital 20
Load More Results